Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lefvert, A. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lefvert, A. K.
NEUROLOGY 1983;33:133
© 1983 American Academy of Neurology

Newborn infants to myasthenic mothers

AL clinical study and an investigation of acetylcholine receptor antibodiesin 17 children

Ann Kari Lefvert and Per Olof Osterman

Department of Clinical Chemistry, Huddinge University Hospital, and the Department of Neurology, Uppsala University Hospital, Sweden.

We studied 17 children born to 15 myasthenic mothers; 2 of the infants had neonatal myasthenia pravis. Pyridostigmine was transferred to the child and accumulated in the amniotic fluid. Sixteen children had receptor antibodies at birth. In the affected infants, the half-life of the receptor antibody concentration was longer than it was in the others. Using an anti-idiotypic antibody, we found marked differences between the idiotypes in the mother and in affected children. Transient synthesis of receptor antibodies in the child seems to be a factor in the pathogenesis of nieonatal myasthenia gravis.

Address correspondence and reprint requests to Dr. Lefvert, Department of Clinical Chemistry, Huddinge University Hospital, S-141 86, Huddinge, Sweden.

This investigation was supported by grants from the Swedish Medical Research Council and the Swedish Society of Medical Sciences.

Accepted for publication June 21, 1982.




This article has been cited by other articles:


Home page
NeurologyHome page
E. H. Niks, A. Verrips, B. A. Semmekrot, M.J.J. Prick, A. Vincent, M. J.D. van Tol, C. M. Jol-van der Zijde, and J. J.G.M. Verschuuren
A TRANSIENT NEONATAL MYASTHENIC SYNDROME WITH ANTI-MUSK ANTIBODIES
Neurology, April 1, 2008; 70(14): 1215 - 1216.
[Full Text] [PDF]


Home page
J. Immunol.Home page
M.-E. Miranda-Carus, A. D. Askanase, R. M. Clancy, F. Di Donato, T.-M. Chou, M. R. Libera, E. K. L. Chan, and J. P. Buyon
Anti-SSA/Ro and Anti-SSB/La Autoantibodies Bind the Surface of Apoptotic Fetal Cardiocytes and Promote Secretion of TNF-{alpha} by Macrophages
J. Immunol., November 1, 2000; 165(9): 5345 - 5351.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. E. Niesen and N. S. Shah
Pyridostigmine-induced microcephaly
Neurology, May 9, 2000; 54(9): 1873 - 1874.
[Full Text] [PDF]


Home page
NeurologyHome page
A. P. Batocchi, L. Majolini, A. Evoli, M. M. Lino, C. Minisci, and P. Tonali
Course and treatment of myasthenia gravis during pregnancy
Neurology, February 1, 1999; 52(3): 447 - 447.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
G. Ahlsten, A.-K. Lefvert, P.-O. Osterman, E. Stalberg, and J. Safwenberg
Follow-up Study of Muscle Function in Children of Mothers With Myasthenia Gravis During Pregnancy
J Child Neurol, July 1, 1992; 7(3): 264 - 269.
[Abstract] [PDF]


Home page
J Child NeurolHome page
O. Papazian
Topical Review Article: Transient Neonatal Myasthenia Gravis
J Child Neurol, April 1, 1992; 7(2): 135 - 141.
[Abstract] [PDF]


Home page
J Child NeurolHome page
J. Z. Heckmatt, M. Placzek, A. H. Thompson, V. Dubowitz, and G. Watson
An Unusual Case of Neonatal Myasthenia
J Child Neurol, January 1, 1987; 2(1): 63 - 66.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1983 by AAN Enterprises, Inc.